Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Neuromuscular Blocking AgentsReversal of Neuromuscular BlockadeRecovery Time
Interventions
DRUG

Sugammadex 1 mg/kg

Patient in experimental arms will receive i.v. sugammadex 1 mg/kg at the end of operating procedure from the point at which a Train-of-Four Count (TOFC) of 2 is observed

DRUG

Neostigmine + Atropine

Patient in active comparators arms will receive i.v. neostigmine 60 mcg/kg along with 0.4 mg of atropine sulfate per 1 mg of neostigmine at the end of operating procedure from the point at which a Train-of-Four Count (TOFC) of 2 is observed

Trial Locations (1)

40161

RECRUITING

Hasan Sadikin General Hospital, Bandung

All Listed Sponsors
lead

Universitas Padjadjaran

OTHER